Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Bordeaux
Clinical trial register · France

Clinical Trials in Bordeaux, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9697 matching records held by the registry are in this view. Synced 26 Oct 2026, 03:20 UTC
9697
Studies in scope
all four open statuses
6025
Recruiting now
open to new participants
1033
Lead sponsors
across recruiting studies
Top sites
Paris 2821 Lyon 1392 Bordeaux 1389 Marseille 1285 Lille 1282
Narrow the registerReset
Recruitment status
Phase
Site location
Paris2821 Lyon1392 Bordeaux1389 Marseille1285 Lille1282
All 804 locations
Target enrolment
to

Trials with a site in Bordeaux

1389 of 9697 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Active, closed
The Lymphoma Academic Research Organisation
Phase 2
141
Avignon, Bayonne, Bordeaux, Caen, Chambéry, Clermont-Ferrand, Créteil, Dijon
2021-06-11
Active, closed
Novartis Pharmaceuticals
Phase 3
1,140
Bordeaux, Clermont-Ferrand, Lyon, Montpellier, Nantes, Paris, Strasbourg, Vandœuvre-lès-Nancy
2021-06-09
Recruiting
ATF Implants
Observational
4,500
Bordeaux, Cornebarrieu, Échirolles, Guilherand-Granges, Marcq-en-Barœul, Nice, Paris, Poitiers
2021-06-07
Recruiting
PROADAPT-ovary/EWOC-2
NCT04284969Ovarian Cancer, Surgery
Hospices Civils de Lyon
Not applicable
292
Bordeaux, Chambéry, Dijon, Lyon, Pierre-Bénite, Pringy, Saint-Priest-en-Jarez, Villejuif
2021-06-03
Active, closed
Biogen
Phase 3
548
Bordeaux, Montpellier, Clermont-Ferrand
2021-05-25
Active, closed
AstraZeneca
Observational
274
Abbeville, Aix-en-Provence, Angers, Antibes, Avignon, Bastia, Bayonne, Bordeaux
2021-05-12
Active, closed
Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer
NCT04940325Metastatic Lung Cancer, Advanced Non Small Cell Lung Cancer, Unresectable Non-small Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
100
Bordeaux, Brest, Caen, Créteil, Paris, Pierre-Bénite, Strasbourg, Villejuif
2021-05-12
Active, closed
Incyte Corporation
Phase 3
899
Caen, Bordeau, Amiens, Bordeaux, La Tronche, Le Chesnay, Le Mans, Lille
2021-05-11
Active, closed
Hoffmann-La Roche
Phase 2
586
Bordeaux, Bron, Clermont-Ferrand, Créteil, Grenoble, Limoges, Marseille, Montpellier
2021-05-05
Active, closed
Abbott Medical Devices
Observational
200
Bordeaux, Lille, Lyon, Rennes, Toulouse
2021-05-04
Active, closed
Hoffmann-La Roche
Phase 3
761
Angers, Avignon, Bordeaux, Clermont-Ferrand, Lyon, Nancy, Paris, Suresnes
2021-05-03
Recruiting
Ipsen
Phase 1/2
240
Bastia, Bordeaux, Brest, Garches
2021-04-29
Active, closed
Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination
NCT04868877Non-Small Cell Lung Cancer Metastatic, Gastric Cancer, Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma
Merus B.V.
Phase 1/2
194
Amiens, Bordeaux, Bron, Créteil, Lille, Marseille, Nantes, Paris
2021-04-28
Recruiting
Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group
NCT03967834Soft Tissue Sarcoma, Clear Cell Sarcoma, Epithelioid Sarcoma, Perivascular Epithelioid Cell Neoplasms
Institut Claudius Regaud
Not applicable
400
Besançon, Bordeaux, Clermont-Ferrand, Dijon, Lille, Limoges, Lyon, Marseille
2021-04-26
Recruiting
Alnylam Pharmaceuticals
Observational
150
Bordeaux, Paris, Toulouse
2021-04-26
Active, closed
AstraZeneca
Phase 3
1,157
Avignon, Besançon, Bordeaux, Caen, Le Mans, Montpellier, Nice, Paris
2021-04-26
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
NCT04752722Superficial Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ, Non-muscle Invasive Bladder Cancer
enGene, Inc.
Phase 1/2
350
Angers, Bordeaux, Lille, Lyon, Paris, Rouen
2021-04-22
Active, closed
Novartis Pharmaceuticals
Phase 2
236
Bordeaux, Dijon, Paris, Tours
2021-04-19
Active, closed
Assistance Publique Hopitaux De Marseille
Not applicable
140
Amiens, Angers, Bordeaux, Dijon, Grenoble, Lille, Lyon, Marseille
2021-04-16
Active, closed
Incyte Corporation
Phase 3
654
Amiens, Angers, Bordeaux, Dijon, Le Chesnay, Nantes, Paris, Pontoise
2021-04-15
Recruiting
Tendyne European Experience Registry
NCT04898335Mitral Regurgitation
LMU Klinikum
Observational
400
Bordeaux, Lille, Rennes, Toulouse
2021-04-15
Active, closed
IDEAYA Biosciences
Phase 1
169
Bordeaux, Toulouse, Marseille, Dijon, Rennes, Villejuif
2021-04-14
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
120
Bordeaux, Paris
2021-04-14
Recruiting
University Hospital, Bordeaux
Phase 3
30
Bordeaux
2021-04-13
Active, closed
OSE2101+FOLFIRI, or FOLFIRI Maintenance After FOLFIRINOX-based Induction Therapy in Advanced or Metastatic PDAC
NCT03806309Pancreatic Ductal Adenocarcinoma, Locally Advanced Cancer, Metastatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
106
Amiens, Beauvais, Besançon, Bordeaux, Brest, Creil, Créteil, Dijon
2021-04-10
Active, closed
Loxo Oncology, Inc.
Phase 3
500
Bordeaux, Paris, Lille, Vandœuvre-lès-Nancy, Politiers, Rouen, Nantes, Pessac
2021-04-08
Recruiting
Gilead Sciences
Phase 1
30
Bordeaux, Lyon, Saint-Herblain
2021-04-06
Active, closed
Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors
NCT03915678Solid Tumor, Adult, Pancreatic Cancer, Virus-associated Tumors, Non Small Cell Lung Cancer
Institut Bergonié
Phase 2
247
Bordeaux, Brest, Caen, Dijon, Lille, Marseille, Paris, Poitiers
2021-03-31
Recruiting
Institut National de la Santé Et de la Recherche Médicale, France
Observational
3,800
Grenoble, Bordeaux, Créteil, Paris
2021-03-30
Recruiting
Molecular Signature From Tumor to Lymph Nodes
NCT04677205Lung Cancer, Stage IIIA-cN2, Operated With Curative Intent, Primary Tumor Tissue Available
Assistance Publique - Hôpitaux de Paris
Observational
200
Bordeaux, Clamart, Marseille, Nice, Paris, Rennes, Strasbourg, Toulouse
2021-03-30
Recruiting
Institut Curie
Phase 2/3
225
Saint-Denis, Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand
2021-03-25
Active, closed
Intergroupe Francophone de Cancerologie Thoracique
Phase 2
54
Aix-en-Provence, Angers, Annecy, Antony, Avignon, Bayonne, Bordeaux, Boulogne
2021-03-19
Active, closed
Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD
NCT04591392Heart Septal Defect, Heart Septal Defects, Atrial, Heart Defects, Congenital, Cardiovascular Abnormalities
atHeart Medical
Not applicable
250
Bordeaux, Lille, Nantes, Paris, Toulouse
2021-03-12
Active, closed
Karyopharm Therapeutics Inc
Phase 3
353
Bordeaux, Clermont-Ferrand, Pierre-Bénite, Brest, Nîmes, Mulhouse, Lille, Tours
2021-03-11
Active, closed
The Lymphoma Academic Research Organisation
Phase 2
62
Bordeaux, Clermont-Ferrand, Créteil, Dijon, Lille, Montpellier, Nantes, Paris
2021-03-10
Active, closed
University Hospital, Bordeaux
Not applicable
500
Bordeaux, Brest, Lille, Paris, Strasbourg
2021-03-10
Recruiting
AstraZeneca
Phase 1
304
Bordeaux, Dijon, Pierre-Bénite, Saint-Herblain, Villejuif
2021-03-09
Recruiting
Elsan
Observational
2,000
Agen, Avignon, Beaumont, Besançon, Bordeaux, Brest, Brive-la-Gaillarde, Cabestany
2021-03-08
Recruiting
Assistance Publique Hopitaux De Marseille
Observational
200
Angers, Bordeaux, Brest, Lille, Limoges, Lyon, Marseille, Montpellier
2021-03-06
Recruiting
Genethon
Phase 2/3
77
Bordeaux, Brest, Bron, Lille, Montpellier, Paris, Strasbourg
2021-03-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
747
Reims, Nice, Strasbourg, Bordeaux, Toulouse, Limoges, Saint-Herblain, Angers
2021-02-25
Active, closed
Hoffmann-La Roche
Phase 3
270
Bordeaux, Créteil, Lille, Montpellier, Pierre-Bénite, Rennes
2021-02-23
Active, closed
AbbVie
Phase 1
81
Marseille, Bordeaux, Paris, Dijon, Toulouse
2021-02-23
Recruiting
PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches
NCT04545502Aneurysm, Dissection, Aortic Root Aneurysm, Aortic Root Dissection
Vascutek Ltd.
Observational
2,000
Bordeaux, Clermont-Ferrand, Dijon, Lille, Marseille, Rennes, Strasbourg, Toulouse
2021-02-17
Recruiting
Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy
NCT04356326Chronic Hypertension Complicating Pregnancy, Pre-Eclampsia, Intrauterine Growth Restriction, Aspirin
Centre Hospitalier Intercommunal Creteil
Phase 3
500
Bordeaux, Caen, Clamart, Colombes, Créteil, Dijon, Le Kremlin-Bicêtre, Lille
2021-02-15
Recruiting
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
108
Libourne, Montpellier, Nîmes, Vandœuvre-lès-Nancy, Bordeaux, Tosse, Angers
2021-02-11
Recruiting
Centre Hospitalier Charles Perrens, Bordeaux
Not applicable
150
Bordeaux
2021-02-08
Recruiting
Institut Cancerologie de l'Ouest
Phase 2
262
Angers, Bordeaux, Montpellier, Nice, Paris, Saint-Herblain, Toulouse
2021-02-03
Recruiting
Université de Sherbrooke
Observational
330
Bordeaux
2021-02-02
Recruiting
AB Science
Phase 3
495
Angers, Bordeaux, Bron, Clermont-Ferrand, Lille, Limoges, Marseille, Montpellier
2021-02-02
Recruiting
Cohort of the Franco-European Multidisciplinary Institute of Endometriosis
NCT07243587Endometriosis, Deep Endometriosis, Pelvic Pain
Clinique Tivoli Ducos
Observational
15,000
Bordeaux
2021-02-01
Active, closed
AstraZeneca
Phase 3
1,371
Besançon, Bordeaux, Brest, Caen, Dijon, Le Mans, Lille, Montpellier
2021-01-28
Active, closed
ENCOrafenib With Binimetinib in bRAF NSCLC
NCT04526782Non Small Cell Lung Cancer, BRAF V600E
Intergroupe Francophone de Cancerologie Thoracique
Phase 2
119
Ambilly, Angers, Avignon, Bordeaux, Boulogne-Billancourt, Brest, Caen, Colmar
2021-01-19
Active, closed
Hoffmann-La Roche
Phase 2
920
Bordeaux, Lille, Lyon, Marseille, Toulouse, Villejuif
2021-01-18
Active, closed
Galderma R&D
Phase 3
500
Bordeaux, Brest, Nantes, Nice, Paris, Pierre-Bénite, Rouen, Saint-Etienne
2021-01-11
Active, closed
Merck Sharp & Dohme LLC
Phase 3
990
Vandœuvre-lès-Nancy, Nice, Caen, Plérin, Besançon, Bordeaux, Toulouse, Montpellier
2021-01-10
Active, closed
BioNTech SE
Phase 2/3
358
Bordeaux, Caen, Dijon, Marseille, Paris, Tours, Villejuif
2021-01-07
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
126
Amiens, Bobigny, Bordeaux, Boulogne-Billancourt, Colombes, Créteil, Lille, Marseille
2021-01-07
Active, closed
A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations
NCT04639219Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast
AstraZeneca
Phase 2
102
Bordeaux, Lyon, Villejuif
2020-12-30
Active, closed
Regeneron Pharmaceuticals
Phase 1/2
548
Lyon, Pierre-Bénite, Dijon, Toulouse, Lille, Bordeaux, Poitiers, Nantes
2020-12-21
Active, closed
Stryker Neurovascular
Observational
405
Amiens, Besançon, Bordeaux, Brest, Clermont-Ferrand, Créteil, La Tronche, Lille
2020-12-21
Active, closed
Janssen Research & Development, LLC
Phase 2
220
Bordeaux, Grenoble, Hyères, Limoges, Lyon, Marseille, Montpellier, Nîmes
2020-12-18
Active, closed
NETRIS Pharma
Phase 1/2
240
Besançon, Bordeaux, Caen, Dijon, Lille, Lyon, Marseille, Montpellier
2020-12-14
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
612
Pierre-Bénite, Dijon, Bordeaux, Caen, Villejuif
2020-12-08
Active, closed
Merck Sharp & Dohme LLC
Phase 3
672
Saint-Quentin, Bordeaux, Marseille, Grenoble, Saint-Herblain, Angers, Bobigny, Toulon
2020-12-08
Active, closed
Janssen Research & Development, LLC
Phase 3
518
Bordeaux, Brest, Caen, Chambray-lès-Tours, Hyères, Lille, Limoges, Lyon
2020-12-07
Active, closed
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
307
Avignon, Besançon, Bordeaux, Caen, Clichy, Creil, Dijon, Grenoble
2020-12-07
Active, closed
Daiichi Sankyo
Phase 3
1,600
Bordeaux, Toulouse, Metz, Saint-Priest-en-Jarez, Dijon, La Roche-sur-Yon, La Tronche, Lille
2020-12-04
Active, closed
Hoffmann-La Roche
Phase 3
864
Bordeaux, Clermont-Ferrand, Lille, Rouen
2020-11-26
Active, closed
Eli Lilly and Company
Phase 3
312
Amiens, Bordeaux, Créteil, Lille, Marseille, Paris
2020-11-25
Active, closed
Science Corporation
Not applicable
38
Lyon, Bordeaux, Créteil, Marseille, Nantes, Paris
2020-11-24
Recruiting
Unity Health Toronto
Not applicable
740
Amiens, Angers, Argenteuil, Beauvais, Bordeaux, Brest, Cholet, Créteil
2020-11-23
Recruiting
Alnylam Pharmaceuticals
Observational
1,500
Bordeaux, Bron, Créteil, Le Kremlin-Bicêtre, Marseille
2020-11-23
Active, closed
Janssen Research & Development, LLC
Phase 1
136
Bordeaux, Saint-Mandé
2020-11-13
Active, closed
Bayer
Phase 4
654
La Tronche (Grenoble Area), Dijon, Brest, Rennes, Reims, Strasbourg, Vandœuvre-lès-Nancy, Bordeaux
2020-11-09
Active, closed
LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)
NCT04446962Lymphoma, Large B-Cell, Diffuse, Central Nervous System Neoplasms, Primary
Institut Curie
Phase 1/2
118
Amiens, Angers, Bayonne, Besançon, Bordeaux, Caen, Clermont-Ferrand, Colmar
2020-10-30
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
NCT04585750Advanced Solid Tumor, Advanced Malignant Neoplasm, Metastatic Cancer, Metastatic Solid Tumor
PMV Pharmaceuticals, Inc
Phase 1/2
300
Strasbourg, Bordeaux, Toulouse, Saint-Herblain, Clermont-Ferrand, Villejuif, Lyon, Nîmes
2020-10-29
Recruiting
Insulin Resistance in Multiple System Atrophy
NCT04250493Multiple System Atrophy
University Hospital, Bordeaux
Not applicable
124
Bordeaux
2020-10-28
Active, closed
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
NCT04595565HER2-negative Breast Cancer, Triple Negative Breast Cancer
GBG Forschungs GmbH
Phase 3
1,332
Angers, Avignon, Bordeaux, Bourg-en-Bresse, Caen, Clermont-Ferrand, Dijon, Lille
2020-10-28
Active, closed
Hoffmann-La Roche
Phase 3
985
Bordeaux, Bron, Montpellier, Nantes, Nice, Strasbourg
2020-10-26
Active, closed
Bayer
Phase 3
402
Clermont-Ferrand, Pierre-Bénite, Dijon, Brest, Rennes, Tours, Reims, Bordeaux
2020-10-20
Recruiting
Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application
NCT03678194Depression, Psychiatric Disorder, Brain Diseases, Central Nervous System Diseases
Centre Hospitalier Charles Perrens, Bordeaux
Not applicable
200
Bordeaux
2020-10-14
Active, closed
University Hospital, Brest
Not applicable
70
Angers, Bordeaux, Grenoble, Lyon, Nantes, Paris, Rennes, Roscoff
2020-10-02
Active, closed
AstraZeneca
Phase 3
370
Avignon, Bordeaux, Clermont-Ferrand, Dijon, Lyon, Marseille, Montpellier, Strasbourg
2020-10-02
Active, closed
Eli Lilly and Company
Phase 1
200
Bordeaux, Villejuif
2020-10-01
Active, closed
University Hospital, Bordeaux
Not applicable
500
Bayonne, Bordeaux
2020-10-01
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
Bordeaux, Bron, La Tronche, Lille, Limoges, Marseille, Paris, Pessac
2020-09-30
Active, closed
argenx
Phase 2
229
Angers, Bordeaux, Clermont-Ferrand, Le Kremlin-Bicêtre, Limoges, Nantes, Nice, Paris
2020-09-18
Recruiting
University of Birmingham
Phase 1/2
1,672
Angers, Besançon, Bordeaux, Brest, Caen, Dijon, Grenoble, La Réunion
2020-09-17
Active, closed
Razor Genomics
Not applicable
420
Bordeaux, Rouen, Angers, Bayonne, Besançon, Boulogne, Clamart, Créteil
2020-09-11
Active, closed
PREdiction of Chronic LUng Allograft Dysfunction
NCT03967340Lung Transplant Rejection
Nantes University Hospital
Observational
240
Bordeaux, Grenoble, Le Plessis-Robinson, Lyon, Marseille, Nantes, Paris, Strasbourg
2020-09-10
Recruiting
University Hospital, Bordeaux
Phase 2
50
Bordeaux
2020-09-10
Active, closed
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
NCT04258137Colorectal Cancer, Non Small Cell Lung Cancer
Institut Bergonié
Not applicable
332
Bayonne, Bordeaux, Brest, Pau
2020-09-04
Recruiting
Pediatric Perioperative Satisfaction Questionnaire
NCT04608968Perioperative, Children, Satisfaction
University Hospital, Montpellier
Observational
600
Montpellier, Bordeaux, Grenoble, Nîmes, Reims, Toulouse
2020-09-01
Active, closed
Philogen S.p.A.
Phase 2
98
Besançon, Bordeaux, Clermont-Ferrand, Lyon, Marseille, Montpellier, Toulouse, Villejuif
2020-08-28
Recruiting
Centre Georges Francois Leclerc
Phase 2
7,976
Amiens, Besançon, Bordeaux, Caen, Dijon, Levallois-Perret, Lille, Nantes
2020-08-25
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
240
Bordeaux, Perpignan, Pierre-Bénite, Angers, Chambéry, Corbeil-Essonnes, Grenoble, Le Mans
2020-08-20
Recruiting
University Hospital, Bordeaux
Phase 3
1,380
Bordeaux
2020-08-07
Active, closed
AstraZeneca
Phase 3
866
Avignon, Besançon, Bordeaux, Brest, Caen, Dijon, Le Mans, Marseille
2020-07-24
Recruiting
University Hospital, Toulouse
Phase 3
310
Bordeaux, Clermont-Ferrand, Créteil, Marseille, Pierre-Bénite, Poitiers, Saint-Herblain, Saint-Pierre
2020-07-17
Active, closed
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
NCT04561362Urinary Bladder Neoplasm, Triple Negative Breast Neoplasms, Hormone Receptor Positive, HER2-negative Neoplasms, Hormone Receptor Positive, HER2-low Neoplasms
BicycleTx Limited
Phase 1/2
329
Bordeaux, Lyon, Marseille, Rennes, Villejuif
2020-07-17
Recruiting
Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib
NCT03651206Ovarian Carcinosarcoma, Endometrial Carcinosarcoma
ARCAGY/ GINECO GROUP
Phase 2/3
138
Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Lille
2020-07-15
Recruiting
Mats Heyman
Phase 3
6,430
Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon
2020-07-13
Active, closed
AstraZeneca
Phase 3
1,012
Besançon, Bordeaux, Marseille, Montpellier, Nice, Paris, Pierre-Bénite, Quimper
2020-07-13
Recruiting
Centre Francois Baclesse
Phase 2
77
Albi, Angers, Bordeaux, Caen, Clermont-Ferrand, Créteil, Dijon, La Roche-sur-Yon
2020-07-01
Recruiting
Institut Claudius Regaud
Phase 2
130
Albi, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dunkirk
2020-06-30
Active, closed
UNICANCER
Phase 3
550
Avignon, Bordeaux, Brest, Caen, Clermont-Ferrand, Creil, Créteil, Jossigny
2020-06-23
Active, closed
Epizyme, Inc.
Phase 3
599
Pessac, Brest, Bordeaux, Mulhouse, Rouen, Limoges, La Tronche, Nantes
2020-06-11
Recruiting
University Hospital, Bordeaux
Not applicable
500
Bordeaux
2020-06-08
Recruiting
Centre Antoine Lacassagne
Phase 2
103
Bordeaux, Caen, Dijon, Lille, Lyon, Marseille, Montpellier, Nice
2020-06-04
Recruiting
Quanta Medical
Not applicable
216
Bordeaux, Cornebarrieu
2020-06-01
Active, closed
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
176
Amiens, Angers, Besançon, Beuvry, Bordeaux, Chauny, Compiègne, Coudekerque-Branche
2020-05-20
Recruiting
Virtual Agents-based Digital Interventions to Improve Health
NCT05074901Mental Disorder, Mental Stress, Insomnia, Depression
University of Bordeaux
Not applicable
20,000
Bordeaux
2020-04-22
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Observational
1,150
Villejuif, Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand
2020-04-09
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
886
Bordeaux, Lyon, Nice, Pierre-Bénite, Strasbourg, Tours, Villejuif-Cedex-France
2020-03-30
Recruiting
University Hospital, Limoges
Observational
1,180
Agen, Amiens, Auxerre, Bayonne, Besançon, Bordeaux, Brest, Bron
2020-03-13
Recruiting
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
NCT04094610Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma, Primary CNS Tumors
Turning Point Therapeutics, Inc.
Phase 1/2
75
Lyon, Angers, Bordeaux, Marseille, Nantes, Paris, Villejuif
2020-03-12
Recruiting
High Resolution Imaging for Analysis of MVNT
NCT04285125Benign Neuronal Desease
Fondation Ophtalmologique Adolphe de Rothschild
Observational
33
Bordeaux, Rennes, Rouen, Toulouse, Paris, Pierre-Bénite, Saint-Herblain
2020-03-05
Active, closed
First-in-Human Study of ICT01 in Patients With Advanced Cancer
NCT04243499Solid Tumor, Adult, Hematopoietic/Lymphoid Cancer
ImCheck Therapeutics, an Ipsen company
Phase 1/2
293
Bordeaux, Lyon, Marseille, Nantes, Nice, Paris, Poitiers
2020-03-05
Recruiting
Centre Leon Berard
Not applicable
168
Besançon, Bordeaux, Lille, Lyon, Marseille, Montpellier, Paris, Poitiers
2020-03-03
Recruiting
Centre Francois Baclesse
Phase 3
368
Pointe à Pitre, Angers, Bordeaux, Brest, Caen, Chambéry, Clermont-Ferrand, Dijon
2020-03-02
Active, closed
Merck Sharp & Dohme LLC
Phase 3
755
Strasbourg, Bordeaux, Caen, Besançon, Nîmes, Vandœuvre-lès-Nancy, Pierre-Bénite, Villejuif
2020-02-27
Active, closed
Immunocore Ltd
Phase 1/2
410
Bordeaux, Villejuif, Lyon, Paris
2020-02-25
Recruiting
National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses
NCT04166266Hepatitis D, Chronic, Hepatitis B, Chronic
ANRS, Emerging Infectious Diseases
Observational
800
Angers, Annecy, Bobigny, Bordeaux, Clermont-Ferrand, Clichy, Créteil, Dijon
2020-02-19
Recruiting
Hospices Civils de Lyon
Phase 1/2
26
Pierre-Bénite, Bordeaux, Caen, Lille, Marseille, Nice, Paris, Rennes
2020-02-12
Active, closed
Loxo Oncology, Inc.
Phase 3
291
Strasbourg, Bordeaux, Lyon, Marseille, Caen, Dijon, Toulouse, Angers
2020-02-11
Active, closed
Centre Georges Francois Leclerc
Phase 2
270
Amiens, Besançon, Bordeaux, Dijon, Levallois-Perret, Lille, Lyon
2020-02-10
Active, closed
Daiichi Sankyo
Phase 1
115
Bordeaux, Créteil, Marseille, Marsielle, Poitiers, Toulouse, Villejuif
2020-02-10
Recruiting
Brain-injured Patients Extubation Readiness Study
NCT04080440Mechanical Ventilator Weaning, Acute Brain Injury, Altered Level of Consciousness, Mechanical Ventilation
University Hospital, Clermont-Ferrand
Not applicable
660
Angers, Bordeaux, Bourg-en-Bresse, Caen, Clermont-Ferrand, Grenoble, La Réunion, Lille
2020-02-09
Recruiting
Nantes University Hospital
Phase 2
25
Bordeaux, Lyon, Nantes, Rennes
2020-02-06
Recruiting
Pregnancy in Women With Rare Multisystemic Vascular Diseases: COGRare5 Study
NCT04194619Vascular Anomaly, Osler Rendu Disease, Marfan Syndrome or Related, Lymphedema Primary
Hospices Civils de Lyon
Observational
400
Angers, Bordeaux, Boulogne-Billancourt, Bron, Caen, Clermont-Ferrand, Dijon, Lille
2020-02-06
Recruiting
Centre Leon Berard
Phase 2
455
Angers, Bordeaux, Caen, Lyon, Marseille, Nice, Paris, Rouen
2020-01-28
Recruiting
Eli Lilly and Company
Phase 2
105
Bordeaux, Lyon, Paris
2020-01-22
Active, closed
BeOne Medicines
Phase 3
955
Bordeaux, La Roche-sur-Yon, Le Mans, Paris, Tours
2020-01-16
By invitation
University Hospital, Bordeaux
Observational
450
Bordeaux
2020-01-14
Active, closed
Regeneron Pharmaceuticals
Phase 1/2
95
Rennes, Bordeaux, Caen, Grenoble, Montpellier
2020-01-07
Recruiting
University Hospital, Limoges
Phase 2
40
Bordeaux, Bron, Le Kremlin-Bicêtre, Limoges, Paris, Rennes, Rouen, Toulouse
2020-01-06
Active, closed
The Netherlands Cancer Institute
Phase 3
538
Besançon, Bordeaux, Lille, Lyon, Montpellier, Nantes, Paris, Strasbourg
2020-01-01
Recruiting
French Colorectal ESD Cohort in Experts Centers
NCT04592003Cancer Colorectal, Polyps Colorectal, Endoscopic Submucosal Resection
University Hospital, Limoges
Observational
1,200
Amiens, Angers, Besançon, Bordeaux, Brest, Dijon, Limoges, Lyon
2020-01-01
Active, closed
Pfizer
Phase 3
1,068
Antony, Bayonne, Bordeaux, Brest, Limoges, Nancy, Paris, Strasbourg
2019-12-30
Recruiting
Natural History of Duchenne Muscular Dystrophy
NCT03882827Duchenne Muscular Dystrophy
Genethon
Observational
220
Bordeaux, Brest, Bron, Lille, Marseille, Montpellier, Paris, Strasbourg
2019-12-19
Active, closed
A Clinical Trial Evaluating TG4050 in Head and Neck Cancer
NCT04183166Squamous Cell Carcinoma of Head and Neck
Transgene
Phase 1/2
80
Bordeaux, Marseille, Paris, Toulouse, Villejuif
2019-12-12
Active, closed
Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase
NCT04070443Philadelphia Chromosome Positive CML, BCR-ABL Positive Chronic Myelogenous Leukemia
Centre Leon Berard
Phase 2
170
Amiens, Angers, Annecy, Avignon, Besançon, Bordeaux, Brest, Caen
2019-11-13
Recruiting
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT04221035High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
800
Villejuif, Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand
2019-11-05
Active, closed
Balt Extrusion
Observational
234
Bordeaux, Brest, Bron, Caen, Clermont-Ferrand, Grenoble, Le Kremlin-Bicêtre, Limoges
2019-11-04
Active, closed
Weaning From High Flow Nasal Oxygen in Acute Respiratory Failure : a Target Trial Emulation
NCT07030413Respiratory Failure With Hypoxia, Respiratory Failure, ICU, High-Flow Nasal Oxygen Therapy
Poitiers University Hospital
Observational
2,000
Bordeaux, Limoges, Poitiers
2019-11-01
Recruiting
Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
NCT04075084Tachycardia, Atrial Fibrillation, Syncope, Bradycardia
Biotronik SE & Co. KG
Observational
1,400
Bordeaux, Brest, Caen, Chambray-lès-Tours, Clermont-Ferrand, Pessac, Strasbourg
2019-10-28
Recruiting
Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department
NCT04104529Thyroid Cancer, Prostate Cancer, Neuroendocrine Tumors, SSTR Positive Tumors
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
350
Bordeaux, Marseille, Montpellier, Toulouse
2019-10-28
Active, closed
Bristol-Myers Squibb
Phase 3
790
Brest, Besançon, Bordeaux, Lille, Marseille, Nantes, Nice, Paris
2019-10-28
Recruiting
GlaxoSmithKline
Phase 1/2
184
Bordeaux, Lille, Marseille, Montpellier, Nantes, Paris, Toulouse
2019-10-25
Active, closed
Gilead Sciences
Phase 2
227
Bordeaux, Dijon, Toulouse, Villejuif
2019-10-15
Recruiting
Associazione Italiana Ematologia Oncologia Pediatrica
Phase 2
89
Bordeaux
2019-10-09
Active, closed
Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK)
NCT04602091Rheumatoid Arthritis, Inflammatory Rheumatism, Psoriatic Arthritis, Spondyloarthritis
Societe Francaise de Rhumatologie
Observational
2,300
Antibes, Bayonne, Belfort, Besançon, Bobigny, Bordeaux, Bourg-en-Bresse, Brest
2019-10-08
Recruiting
Center Eugene Marquis
Not applicable
240
Albi, Angers, Bordeaux, Dijon, La Garenne-Colombes, Levallois-Perret, Lyon, Montpellier
2019-10-04
Active, closed
MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas
NCT03697512Marginal Zone Lymphoma, Nodal Marginal Zone Lymphoma, Splenic Marginal Zone Lymphoma
International Extranodal Lymphoma Study Group (IELSG)
Phase 2
175
Tours, Montpellier, Clermont-Ferrand, Rennes, Bordeaux, Caen, Dijon, La Tronche
2019-09-27
Recruiting
University Hospital, Limoges
Not applicable
214
Bordeaux, Brive-la-Gaillarde, Clermont-Ferrand, Guéret, Limoges, Saint-Etienne, Toulouse, Tulle
2019-09-27
Recruiting
Centre Hospitalier de PAU
Observational
1,200
Annecy, Bayonne, Bobigny, Bordeaux, Chalon-sur-Saône, Chambéry, Clermont-Ferrand, Créteil
2019-09-20
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
NCT04104776Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell, Mesothelioma, Malignant
Novartis Pharmaceuticals
Phase 1/2
300
Bordeaux, Lille, Lyon, Nantes, Saint-Herblain, Strasbourg, Villejuif
2019-09-18
Active, closed
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
NCT04083599Malignant Solid Tumor, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Melanoma
Genmab
Phase 1/2
350
Bordeaux, Nice, Villejuif
2019-09-17
Active, closed
Janssen Research & Development, LLC
Phase 1
701
Bordeaux, Lyon, Marseille, Paris, Poitiers, Saint-Mandé, Villejuif
2019-09-04
Active, closed
ETOP IBCSG Partners Foundation
Phase 3
405
Avignon, Bordeaux, Caen, Cholet, Dijon, Limoges, Lorient, Lyon
2019-08-27
Recruiting
University Hospital Muenster
Phase 3
683
Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon
2019-08-23
Recruiting
University Hospital, Bordeaux
Observational
200
Bordeaux
2019-08-23
Active, closed
BeOne Medicines
Phase 3
510
Bordeaux, Brest, Dijon, Grenoble, Le Mans, Lille, Marseille, Nantes
2019-08-20
Recruiting
Unruptured Cerebral Aneurysm: Prediction of Evolution
NCT04578808Unruptured Intracranial Aneurysm
Nantes University Hospital
Observational
1,000
Marseille, Brest, Bordeaux, Toulouse, Limoges, Rennes, Tours, Nantes
2019-08-19
Active, closed
Sanofi
Observational
1,860
Argenteuil, Bordeaux, Lille, Marseille, Martigues, Nantes, Paris, Toulouse
2019-08-15
Recruiting
French Registry for Monitoring Pregnancies for Multiple Sclerosis
NCT03900221Sclerosis, Multiple, Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders, Pregnancy Abnormal
Hospices Civils de Lyon
Observational
1,500
Amiens, Annecy, Avignon, Besançon, Bordeaux, Brive-la-Gaillarde, Bron, Caen
2019-08-12
Active, closed
Hoffmann-La Roche
Phase 3
1,013
Bordeaux, Clermont-Ferrand, Nancy, Nantes, Nîmes, Strasbourg
2019-08-12
Recruiting
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
NCT04068597Haematological Malignancy, Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma
CellCentric Ltd.
Phase 1/2
250
Bordeaux, Villejuif
2019-08-09
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Bordeaux, Vandœuvre-lès-Nancy, Clermont-Ferrand, Créteil, Dijon, La Tronche, Lille, Marseille
2019-08-09
Active, closed
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor
NCT04008797Endometrial Neoplasms, Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms
Eisai Inc.
Phase 1/2
301
Amiens, Bordeaux, Brest, Caen, Clermont-Ferrand, Clichy, Dijon, La Tronche
2019-07-11
Active, closed
University Hospital, Rouen
Phase 3
92
Amiens, Angers, Argenteuil, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon
2019-07-11
Active, closed
Exelixis
Phase 3
855
Bordeaux, Le Mans, Lyon, Montpellier, Nice, Paris, Reims, Rennes
2019-06-25
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
366
Bordeaux, Brou, Caen, Clermont-Ferrand, La Roche-sur-Yon, Lille, Limoges, Lyon
2019-06-14
Active, closed
Janssen Research & Development, LLC
Phase 3
2,517
Angers, Besançon, Bordeaux, Créteil, Lyon, Nantes, Paris, Quint-Fonsegrives
2019-06-11
Active, closed
Sanofi
Observational
955
Antony, Bordeaux, Montpellier, Pierre-Bénite, Rouen, Saint-Mandé Cedex, Toulouse, Valence
2019-06-11
Active, closed
Regeneron Pharmaceuticals
Phase 3
415
Dijon, Bordeaux, Boulogne-Billancourt, La Tronche, Lille, Lyon, Nantes, Nice
2019-06-04
Active, closed
Eisai Inc.
Phase 2
100
Marseille, Bordeaux, Paris, Rennes, Toulouse
2019-05-31
Active, closed
LEO Pharma
Phase 2
131
Bordeaux, Nice, Paris, Reims
2019-05-29
Active, closed
Centre Hospitalier Universitaire de Nīmes
Observational
1,150
Amiens, Besançon, Bordeaux, Caen, Clermont-Ferrand, Créteil, Dijon, Grenoble
2019-05-22
Active, closed
French Innovative Leukemia Organisation
Phase 2
82
Amiens, Angers, Annecy, Bayonne, Besançon, Béziers, Blois, Bordeaux
2019-05-22
Active, closed
Celgene
Phase 1/2
438
Bordeaux, Créteil, Lille, Montpellier, Paris, Pierre-Bénite, Rouen, Toulouse
2019-05-20
Active, closed
Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breast
NCT03878342DCIS, Breast Cancer, Low Risk DCIS, Breast Conserving Surgery
UNICANCER
Not applicable
295
Angers, Avignon, Bayonne, Bordeaux, Caen, Cherbourg, Clermont-Ferrand, Créteil
2019-05-10
Active, closed
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI)
NCT03842982Ovary Neoplasms, Ovarian Cancer, Ovarian Carcinoma
DrugHipec
Centre Oscar Lambret
Phase 3
362
Angers, Bordeaux, Caen, Clermont-Ferrand, Lille, Marseille, Montpellier, Paris
2019-05-03
Recruiting
LISA Post Market Clinical Follow-Up Study: Documentation of Clinical Outcomes After Surgery With LISA Implant
NCT04631133Chronic Low-back Pain, Herniated Disc, Degenerative Disc Disease, Lumbar Canal Stenosis
BACKBONE
Observational
136
Bordeaux, Lyon, Paris
2019-04-17
Active, closed
IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome
NCT03744390Myelodysplastic Syndromes, Leukemia Acute Myeloid
Groupe Francophone des Myelodysplasies
Phase 2
68
Versailles, Montpellier, Angers, Argenteuil, Bayonne, Bordeaux, Caen, Créteil
2019-04-02
Active, closed
Institut Cancerologie de l'Ouest
Phase 2
96
Bordeaux, Brest, Dijon, Lille, Lorient, Lyon, Montpellier, Pierre-Bénite
2019-03-21
Active, closed
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
NCT03845166Neoplasm Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma, Metastatic Castration-resistant Prostate Cancer
Exelixis
Phase 1
325
Clermont, Saint-Herblain, Bordeaux, Caen, Marseille, Paris, Pierre-Bénite, Poitiers
2019-03-20
Recruiting
Institut Bergonié
Phase 3
351
Bordeaux, Dijon, Limoges, Lyon, Marseille, Montpellier, Saint-Herblain, Strasbourg
2019-02-14
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 3
453
Bordeaux, Dijon, Lille, Lyon, Marseille, Paris, Poitiers, Saint-Herblain
2019-02-08
Recruiting
University Hospital, Tours
Observational
150
Bordeaux, Grenoble, Lyon, Marseille, Nantes, Nice, Paris, Rennes
2019-02-04
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Besançon, Bordeaux, Clermont-Ferrand, Lyon, Montpellier, Nancy, Nice, Paris
2019-01-25
Active, closed
Rennes University Hospital
Phase 3
250
Angers, Bordeaux, Brest, Chartres, Clermont-Ferrand, Créteil, Dijon, Grenoble
2019-01-24
Recruiting
Centre Leon Berard
Phase 2
40
Besançon, Bordeaux, Caen, Clermont-Ferrand, Lille, Limoges, Lyon, Marseille
2019-01-23
Active, closed
UNICANCER
Phase 3
517
Angers, Bordeaux, Clermont-Ferrand, Ermont, Grenoble, Hyères, Le Kremlin-Bicêtre, Lille
2019-01-17
Recruiting
RECORDATI GROUP
Observational
95
Bordeaux, Marseille, Nancy, Paris, Rouen, Strasbourg
2019-01-15
Active, closed
AstraZeneca
Phase 3
1,407
Besançon, Bordeaux, Limoges, Lyon, Marseille, Nantes, Paris, Saint-Herblain
2019-01-04
Active, closed
9-ING-41 in Patients With Advanced Cancers
NCT03678883Cancer, Pancreatic Cancer, Sarcoma, Renal Cancer
Actuate Therapeutics Inc.
Phase 2
350
Besançon, Brest, Lille, Vandœuvre-lès-Nancy, Bordeaux, Saint-Herblain, Marseille
2019-01-04
Active, closed
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
45
Paris, Villejuif, Bordeaux, Créteil, Lille, Lyon, Toulouse, Vandœuvre-lès-Nancy
2019-01-02
Active, closed
Jules Bordet Institute
Phase 1/2
129
Besançon, Bordeaux, Dijon, Marseille, Nice, Paris, Poitiers, Rouen
2018-12-28
Active, closed
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
NCT03614260Hypertension, Vascular Diseases, Cardiovascular Diseases
ReCor Medical, Inc.
Not applicable
224
Bordeaux, Lille, Paris
2018-12-14
Active, closed
UNICANCER
Phase 2
79
Bordeaux, Clermont-Ferrand, Dijon, Lille, Montpellier, Mougins, Nice, Paris
2018-12-14
Active, closed
Merck Sharp & Dohme LLC
Phase 2
329
Poitiers, Nice, Strasbourg, Dijon, Bordeaux, Villejuif
2018-12-12
Active, closed
Institut Cancerologie de l'Ouest
Not applicable
256
Avignon, Bordeaux, Brest, Chalon-sur-Saône, Clermont-Ferrand, Dijon, Lille, Lyon
2018-12-04
Active, closed
Eli Lilly and Company
Phase 2/3
393
Lyon, Montpellier, Le Mans, La Roche-sur-Yon, Bordeaux, Créteil
2018-11-26
Recruiting
REal World Data in LYmphoma and Survival in Adults
NCT03869619Diffuse Large B Lymphoma (DLBCL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL)
Hospices Civils de Lyon
Observational
6,000
Arras, Besançon, Bordeaux, Bourgoin, Caen, Chambéry, Clermont-Ferrand, Créteil
2018-11-14
Active, closed
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
106
Besançon, Bordeaux, Boulogne-sur-Mer, Brest, Clichy, Creil, Créteil, Dijon
2018-11-09
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
271
Amiens, Besançon, Bordeaux, Clermont-Ferrand, Dijon, Grenoble, Lille, Lyon
2018-10-30
Active, closed
Janssen Research & Development, LLC
Phase 3
84
Bordeaux, Paris
2018-10-29
Active, closed
UNICANCER
Phase 2
60
Amiens, Angers, Bordeaux, Caen, La Tronche, Lille, Lyon, Marseille
2018-10-23
Active, closed
Tesaro, Inc.
Phase 3
1,400
Angers, Avignon, Besançon, Bordeaux, Bron, Caen, Cholet, Clermont-Ferrand
2018-10-11
Active, closed
AbbVie
Phase 2
270
Marseille, Bordeaux, Lille, Paris, Bron, Lyon, Créteil, Villejuif
2018-10-10
Active, closed
Exelixis
Phase 3
187
Dijon, Bordeaux, Angers, Marseille, Besançon, Lyon, Nice, Paris
2018-10-05
Active, closed
Hospices Civils de Lyon
Phase 3
108
Aix-en-Provence, Besançon, Bordeaux, Colmar, Lille, Lyon, Marseille, Paris
2018-10-02
Recruiting
Hoffmann-La Roche
Phase 3
1,000
Bordeaux, Lyon, Marseille, Paris
2018-09-20
Active, closed
Merck Sharp & Dohme LLC
Phase 3
976
Marseille, Dijon, Bordeaux, Toulouse, Boulogne-Billancourt, Montpellier, Rennes, Angers
2018-09-12
Recruiting
University of Leeds
Observational
500
Bordeaux
2018-09-01
Active, closed
Institut Paoli-Calmettes
Phase 2
52
Amiens, Avignon, Bordeaux, Caen, Dijon, Lyon, Paris, Rouen
2018-08-29
Active, closed
Gilead Sciences
Phase 2
502
Besançon, Bordeaux, Brest, Clermont-Ferrand, La Roche-sur-Yon, Lille, Lyon, Marseille
2018-08-13
Active, closed
AbbVie
Phase 3
1,533
Nice, Marseille, Tours, Bordeaux, Reims
2018-08-09
Active, closed
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
352
Villejuif, Angers, Bordeaux, Bron, Caen, Clermont-Ferrand, Dijon, Haguenau
2018-08-08
Active, closed
Centre Leon Berard
Phase 2
62
Bordeaux, Lille, Lyon, Toulouse, Villejuif
2018-08-01
Active, closed
Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases
NCT03143322Metastatic Breast Cancer, Metastatic Lung Cancer, Metastatic Prostate Cancer, Bone Metastases
UNICANCER
Not applicable
168
Angers, Arras, Avignon, Beuvry, Bordeaux, Chambéry, Chambray-lès-Tours, Creil
2018-07-24
Recruiting
University Hospital, Grenoble
Not applicable
90
Amiens, Angers, Besançon, Bordeaux, Clichy, Grenoble, Paris, Poitiers
2018-07-17
Active, closed
OFSEP High Definition Cohort
NCT03603457Multiple Sclerosis
EDMUS Foundation
Observational
2,842
Besançon, Bordeaux, Caen, Clermont-Ferrand, Créteil, Dijon, Grenoble, Lille
2018-07-10
Active, closed
Clinical Database of Colorectal Robotic Surgery
NCT04013152Crohn Disease, Polyposis, Ulcerative Colitis, Diverticulitis
Institut du Cancer de Montpellier - Val d'Aurelle
Observational
1,800
Bordeaux, Montpellier, Clermont-Ferrand, Lyon
2018-06-13
Recruiting
University Hospital, Montpellier
Phase 2
40
Amiens, Angers, Bordeaux, Dijon, Montpellier, Paris, Villejuif
2018-06-11
Recruiting
Institut Bergonié
Not applicable
15
Bordeaux
2018-06-07
Active, closed
Genentech, Inc.
Phase 1
123
Bordeaux, Lyon, Villejuif, Toulouse
2018-06-06
Recruiting
Gelscom SAS
Not applicable
230
Bordeaux, Saint-Dié, Saint-Pierre, Saint-Priest-en-Jarez, Valence
2018-05-29
Active, closed
Hoffmann-La Roche
Phase 3
927
Bayonne, Bordeaux, Bron, Caen, Clermont-Ferrand, Lille, Marseille, Montpellier
2018-05-28
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
890
Pierre-Bénite, Dijon, Bordeaux, Caen, Nice, Lyon, Villejuif
2018-05-21
Active, closed
AstraZeneca
Phase 3
1,018
Amiens, Angers, Bordeaux, Lyon, Marseille, Montpellier, Strasbourg, Suresnes
2018-05-14
Active, closed
Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy
NCT03418844Germ Cell Tumor, Sex Cord Stromal Tumor, Malignant Non-epithelial Ovarian Tumors
Centre Francois Baclesse
Not applicable
268
Paris, Angers, Besançon, Bordeaux, Bourg-en-Bresse, Caen, Clermont-Ferrand, Lyon
2018-05-07
Active, closed
Centre Hospitalier Universitaire de Besancon
Not applicable
989
Saint-Denis, Paris, Amiens, Besançon, Bordeaux, Caen, Clamart, Clermont-Ferrand
2018-05-03
Recruiting
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
NCT03526835Advanced/Metastatic Solid Tumors, Colorectal Cancer, Gastric Cancer, Gastroesophageal-junction Cancer
Merus B.V.
Phase 1/2
560
Bordeaux, Lyon, Marseille, Montpellier, Nice, Paris, Rouen
2018-05-02
Active, closed
MedImmune LLC
Phase 1
400
Bordeaux, Lyon, Villejuif
2018-04-24
Active, closed
Centre Hospitalier Universitaire de Nīmes
Not applicable
300
Béziers, Bordeaux, Bron, Clermont-Ferrand, Créteil, Grenoble, Limoges, Marseille
2018-04-24
Active, closed
Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO)
NCT03496402Neuroblastoma, Rhabdomyosarcoma, Ewing Sarcoma Family of Tumors, Osteosarcoma
Institut Curie
Not applicable
600
Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon
2018-04-20
Active, closed
UNICANCER
Not applicable
81
Angers, Bordeaux, Caen, Dijon, Grenoble, Lille, Limoges, Lorient
2018-04-19
Active, closed
Hospices Civils de Lyon
Observational
670
Amiens, Angers, Bordeaux, Clichy, Dijon, Lille, Lyon, Marseille
2018-04-16
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
Rennes, Amiens, Bordeaux, Lille, Marseille, Paris, Pierre-Bénite, Poitiers
2018-04-11
Active, closed
Merck Sharp & Dohme LLC
Phase 2
340
Lyon, Marseille, Bordeaux, Lille, Villejuif, Paris
2018-04-09
Active, closed
Janssen Research & Development, LLC
Phase 1/2
125
Angers, Bordeaux, Caen, La Rochelle, Lyon, Marseille, Paris, Strasbourg
2018-04-05
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Angers, Besançon, Bordeaux, Brest, Clermont-Ferrand, Dijon, Lille, Lorient
2018-03-23
Active, closed
Orion Corporation, Orion Pharma
Phase 1/2
204
Bordeaux, Lyon, Marseille, Strasbourg, Suresnes, Villejuif
2018-03-19
Active, closed
AstraZeneca
Phase 2
273
Angers, Besançon, Bordeaux, Caen, Lille, Lyon, Marseille, Montpellier
2018-03-07
Recruiting
FARD (RaDiCo Cohort) (RaDiCo-FARD)
NCT05954416Inherited Epidermolysis Bullosa, Ichthyosis, Ectodermal Dysplasia, Incontinentia Pigmenti
Institut National de la Santé Et de la Recherche Médicale, France
Observational
900
Bobigny, Bordeaux, Créteil, Dijon, Limoges, Marseille, Montpellier, Nice
2018-03-07
Active, closed
Nantes University Hospital
Not applicable
330
Angers, Annecy, Bordeaux, Brest, Créteil, Grenoble, Le Plessis-Robinson, Lille
2018-03-02
Active, closed
Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease
NCT03323476Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, End Stage Renal Disease
Centre Hospitalier Departemental Vendee
Phase 3
136
Amiens, Angers, Angoulême, Arras, Avignon, Avranches, Besançon, Bordeaux
2018-02-02
Active, closed
PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer
NCT03774732Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, Non-Small Cell Carcinoma of Lung, TNM Stage 4
UNICANCER
Phase 3
327
Angers, Arras, Avignon, Beuvry, Blois, Bordeaux, Brest, Caen
2018-01-24
Recruiting
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
NCT03328078Relapsed Hematologic Malignancy, Refractory Hematologic Malignancy, Relapsed Primary Central Nervous System Lymphoma, Refractory Primary Central Nervous System Lymphoma
Curis, Inc.
Phase 1/2
152
Bordeaux, Marseille, Paris
2017-12-28
Recruiting
MPS (RaDiCo Cohort) (RaDiCo-MPS)
NCT06036693Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis III, Mucopolysaccharidosis IV
Institut National de la Santé Et de la Recherche Médicale, France
Observational
1,000
Angers, Bordeaux, Brest, Clermont-Ferrand, Clichy, Garches, Lille, Marseille
2017-12-20
Active, closed
AstraZeneca
Phase 2
528
Bordeaux, Nantes, Paris, Villejuif
2017-12-18
Active, closed
Pfizer
Phase 3
1,054
Le Mans, Bayonne, Bordeaux, La Roche-sur-Yon, Lyon, Montpellier, Paris, Strasbourg
2017-12-18
Active, closed
Institut Bergonié
Not applicable
25
Bordeaux
2017-11-30
Recruiting
Centre Hospitalier Universitaire de la Réunion
Not applicable
75
Bordeaux, Limoges, Nantes, Rennes, Saint-Denis
2017-11-28
Active, closed
COLPAC (RaDiCo Cohort) (RaDiCo-COLPAC)
NCT05961826Low Phospholipid Associated Cholelithiasis
Institut National de la Santé Et de la Recherche Médicale, France
Observational
650
Aix-en-Provence, Annecy, Bobigny, Bordeaux, Bry-sur-Marne, Caen, Clichy, Corbeil-Essonnes
2017-11-06
Active, closed
BeiGene
Phase 3
590
Argenteuil, Bordeaux, Caen, La Roche-sur-Yon, Le Mans, Limoges, Marseille, Nantes
2017-10-31
Active, closed
Endurant CHevAr New Indication Trial: ENCHANT
NCT03320252AAA - Abdominal Aortic Aneurysm
Medtronic Cardiovascular
Observational
150
Bordeaux, Boulogne-Billancourt
2017-10-26
Active, closed
Janssen-Cilag International NV
Observational
135
Argenteuil, Besançon, Bordeaux, Brest, Martigues, Paris, Saint-Etienne
2017-10-25
Recruiting
Pathophysiological Explorations of Red Blood Cells
NCT03541525Red Blood Cell Disorder
Imagine Institute
Observational
3,750
Amiens, Antony, Bobigny, Bordeaux, Clichy, Colombes, Créteil, Le Kremlin-Bicêtre
2017-10-16
Recruiting
UNICANCER
Observational
75,000
Angers, Bordeaux, Caen, Clermont-Ferrand, Créteil, Dijon, Lille, Lyon
2017-10-02
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
Bordeaux, Caen, Lille, Lyon, Nîmes, Nouilly, Paris, Poitiers
2017-09-22
Active, closed
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
NCT03212404Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Small Cell, Malignant Mesothelioma, Advanced
Checkpoint Therapeutics, Inc.
Phase 1
272
Besançon, Bordeaux, Grenoble, Lyon, Nice
2017-09-20
Active, closed
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)
NCT03767348Non-Small Cell Lung Cancer (NSCLC), Microsatellite Instability-High (MSI-H), Non-melanoma Skin Cancer (NMSC), Cutaneous Melanoma
Replimune, Inc.
Phase 2
340
Besançon, Bordeaux, Dijon, Lyon, Marseille, Nice, Paris, Villejuif
2017-09-20
Recruiting
Registry for Patients With X-Linked Hypophosphatemia
NCT03193476X-Linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd
Observational
1,489
Bordeaux, Bron, Lille, Montpellier, Nantes, Paris, Toulouse
2017-09-12
Active, closed
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
NCT03170960Urothelial Carcinoma, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Castration-resistant Prostate Cancer
Exelixis
Phase 1
914
La Roche-sur-Yon, Villejuif, Bordeaux, Brest, Caen, Le Mans, Lille, Lyon
2017-09-05
Active, closed
Centre Francois Baclesse
Phase 1/2
91
Amiens, Angers, Bordeaux, Caen, Le Havre, Lorient, Lyon, Paris
2017-09-04
Active, closed
Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers
NCT03260023HPV-Related Carcinoma, HPV-Related Cervical Carcinoma, HPV-Related Anal Squamous Cell Carcinoma, HPV-Related Penile Squamous Cell Carcinoma
Transgene
Phase 1/2
143
Angers, Besançon, Bordeaux, Colmar, Dijon, Lyon, Marseille, Paris
2017-09-01
Active, closed
Savolitinib vs. Sunitinib in MET-driven PRCC.
NCT03091192Carcinoma, Carcinoma, Renal Cell, Kidney Neoplasms, Urologic Neoplasms
AstraZeneca
Phase 3
60
Bordeaux, Vandœuvre-lès-Nancy, Villejuif
2017-07-25
Active, closed
University Hospital, Bordeaux
Observational
7,500
Agen, Angoulême, Bayonne, Bordeaux, Dax, Jonzac, La Teste-de-Buch, Libourne
2017-07-18
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
1,200
Bordeaux, Caen, Limoges, Nancy, Nantes, Paris, Rennes, Suresnes
2017-07-13
Active, closed
Hoffmann-La Roche
Phase 2
316
Bordeaux, Clermont-Ferrand, Créteil, Grenoble, Marseille, Nice, Paris, Poitiers
2017-06-27
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
518
Angers, Avignon, Bordeaux, Caen, Cholet, Clermont-Ferrand, Dijon, Lille
2017-06-21
Recruiting
Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry
NCT04220970Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL)
The Lymphoma Academic Research Organisation
Observational
150
Avignon, Bordeaux, Brest, Colmar, Créteil, Dijon, Lille, Lyon
2017-06-07
Active, closed
Osseointegration of THA Grafted by PolyNASS (ACTISURF-CERAFIT® ) Versus Non-grafted THA (CERAFIT®)
NCT03113981Osteoarthritis, Hip, Coxarthrosis; Primary, Coxarthrosis; Secondary, Osteonecrosis; Aseptic, Idiopathic
Societe ACTIVBIOMAT
Not applicable
340
Bordeaux, Boulogne-Billancourt, Brest, Paris, Quimper, Strasbourg
2017-05-08
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
4,975
Avignon, Besançon, Beuvry, Bordeaux, Boulogne-sur-Mer, Bron, Caen, Créteil
2017-05-03
Active, closed
Eli Lilly and Company
Phase 1/2
857
Bordeaux, Lyon, Marseille, Montpellier, Villejuif, Paris
2017-05-02
Recruiting
DCP (RaDiCo Cohort) (RaDiCo-DCP)
NCT05951478Primary Ciliary Dyskinesia
Institut National de la Santé Et de la Recherche Médicale, France
Observational
300
Besançon, Bordeaux, Caen, Créteil, Dijon, Le Kremlin-Bicêtre, Lille, Lyon
2017-05-01
Active, closed
Acerta Pharma BV
Phase 3
635
Argenteuil, Bobigny, Bordeaux, Le Mans, Limoges, Pessac, Périgueux, Rennes
2017-04-05
Active, closed
AbbVie
Phase 1
163
Bordeaux, Montpellier, Lyon, Villejuif
2017-02-22
Active, closed
Materiovigilance After Urinary Incontinence or Prolapse Surgery
NCT03052985Pelvic Organ Prolapse, Rectal Prolapse, Urinary Stress Incontinence
Poitiers University Hospital
Observational
19,000
Aix-en-Provence, Angers, Besançon, Béthune, Bordeaux, Caen, Châtellerault, Clamart
2017-02-14
Active, closed
Acerta Pharma BV
Phase 3
310
Bordeaux, Brest, Montpellier, Nantes, Paris, Perpignan, Provence Alpes Cote D'Azur, Rennes
2017-02-02
Active, closed
Société Française d'Endoscopie Digestive
Observational
100
Amiens, Angers, Besançon, Bordeaux, Clichy, Dijon, Lyon, Marseille
2017-01-10
Recruiting
Institut Curie
Not applicable
1,050
Bordeaux, Lille, Lyon, Paris, Saint-Cloud, Vandœuvre-lès-Nancy
2017-01-06
Recruiting
University College, London
Observational
2,500
Angers, Bordeaux
2017-01-01
Active, closed
AstraZeneca
Phase 1
117
Bordeaux, Caen, Lyon, Marseille, Saint-Herblain, Toulouse
2016-12-28
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Bordeaux, La Roche-sur-Yon, Lille, Lyon, Montpellier, Nîmes, Paris, Saint-Herblain
2016-12-22
Active, closed
SEDVasc (RaDiCo Cohort) (RaDiCo-SEDVasc)
NCT05976841Ehlers-Danlos Syndrome, Vascular Type
Institut National de la Santé Et de la Recherche Médicale, France
Observational
340
Angers, Bordeaux, Brest, Caen, Clermont-Ferrand, Grenoble, Lille, Lyon
2016-12-05
Recruiting
Federation Francophone de Cancerologie Digestive
Phase 3
348
Angers, Antony, Avignon, Bayonne, Beauvais, Bordeaux, Caluire-et-Cuire, Challans
2016-12
Active, closed
Centre Oscar Lambret
Not applicable
140
Bondy, Bordeaux, Caen, Clamart, Dijon, La Réunion, Lille, Limoges
2016-12
Recruiting
Neurovascular Product Surveillance Registry
NCT02988128Intracranial Aneurysm, Stroke, Ischemic
Medtronic Neurovascular Clinical Affairs
Observational
4,000
Besançon, Bordeaux, Brest, Bron, Caen, Clermont-Ferrand, Dijon, Le Kremlin-Bicêtre
2016-12
Active, closed
UNICANCER
Phase 2
37
Angers, Besançon, Bordeaux, Caen, Clermont-Ferrand, Limoges, Lyon, Marseille
2016-10-17
Active, closed
The Lymphoma Academic Research Organisation
Phase 1/2
214
Clermont-Ferrand, Argenteuil, Avignon, Besançon, Bordeaux, Chambéry, Créteil, Dijon
2016-10
Active, closed
Assistance Publique - Hôpitaux de Paris
Phase 3
2,044
Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon
2016-09-19
Active, closed
UNICANCER
Not applicable
1,265
Amiens, Angers, Besançon, Bordeaux, Clermont-Ferrand, Créteil, Dijon, Le Havre
2016-09
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1/2
472
Villejuif, Angers, Bordeaux, Lille, Lyon, Marseille, Nantes, Paris
2016-08-03
Active, closed
Versailles Hospital
Phase 1/2
100
Angers, Annecy, Bobigny, Bordeaux, Caen, Clermont-Ferrand, Créteil, Le Chesnay
2016-07
Active, closed
AGO Study Group
Not applicable
797
Bordeaux, Paris, Villejuif
2016-07
Recruiting
Institut Bergonié
Not applicable
205
Bordeaux, Dijon, Lille, Lyon, Marseille, Nantes, Paris, Toulouse
2016-06
Active, closed
Janssen Research & Development, LLC
Phase 1
751
Bordeaux, Dijon, Lyon, Marseille, Paris, Saint-Herblain, Villejuif
2016-05-24
Active, closed
Eli Lilly and Company
Phase 2
309
Lyon, Bordeaux, Besançon, Lille, Montpellier, Nice, Villejuif
2016-05-19
Active, closed
University of Birmingham
Phase 3
700
Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon
2016-04
Active, closed
Centre Oscar Lambret
Not applicable
628
Angers, Besançon, Bordeaux, Caen, Clermont-Ferrand, Dijon, Grenoble, Lille
2016-03-22
Active, closed
AstraZeneca
Phase 1/2
264
Bordeaux, Caen, Clermont-Ferrand, Dijon, Marseille, Nantes, Paris, Pierre Benit Cedex
2016-03-17
Active, closed
Acerta Pharma BV
Phase 2
60
Bordeaux
2016-03-08
Active, closed
Tesaro, Inc.
Phase 1
729
Bordeaux, Caen, Clermont-Ferrand, Lille, Marseille, Paris, Saint-Herblain, Villejuif
2016-03-07
Active, closed
ReCor Medical, Inc.
Not applicable
282
Bordeaux, Lille, Lyon, Paris, Toulouse
2016-03
Active, closed
AbbVie
Phase 3
1,629
Toulouse, Lille, Montpellier, Bordeaux, Caen, Clermont-Ferrand, Marseille, Paris
2015-12-01
Recruiting
Institut Bergonié
Not applicable
10,000
Bayonne, Bordeaux, Pau, Rennes
2015-12
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
Amiens, Angers, Avignon, Bayonne, Besançon, Bordeaux, Brest, Dijon
2015-11-19
Active, closed
Hoffmann-La Roche
Phase 2
534
Angers, Bordeaux, Lyon, Marseille, Montpellier, Paris, Toulouse, Villejuif
2015-11-19
Active, closed
AstraZeneca
Phase 3
1,126
Bordeaux, Caen, Lyon, Marseille, Paris, Poitiers, Suresnes, Toulouse
2015-11-02
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 4
820
Bordeaux, Paris
2015-09
Active, closed
AstraZeneca
Phase 3
1,118
Bordeaux, Brest, Créteil, Lille, Lyon, Marseille
2015-07-21
Active, closed
Taiho Oncology, Inc.
Phase 1/2
253
Villejuif, Pierre-Bénite, Bordeaux, Nice, Rouen, Toulouse, Tours
2015-07-14
Active, closed
Medtronic
Observational
3,100
Annecy, Bayonne, Bordeaux, Brest, Chambray-lès-Tours, Clermont-Ferrand, Grenoble, Lille
2015-07
Recruiting
Centre Leon Berard
Phase 2/3
536
Strasbourg, Marseille, Dijon, Besançon, Brest, Bordeaux, Toulouse, Montpellier
2015-06-02
Active, closed
Janssen Research & Development, LLC
Phase 2
239
Angers, Bordeaux, Caen Cédex 05, Dijon, Lyon, Nice, Nîmes, Paris
2015-04-22
Active, closed
Exelixis
Phase 4
247
Bordeaux, Angers, Lyon, Villejuif, Dijon, Paris, Strasbourg
2015-02-25
Active, closed
ViiV Healthcare
Phase 3
371
Bordeaux, Marseille, Nantes, Paris
2015-02-23
Active, closed
Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma
NCT02243605Metastatic Ewing Sarcoma, Metastatic Osteosarcoma, Recurrent Ewing Sarcoma, Recurrent Osteosarcoma
National Cancer Institute (NCI)
Phase 2
90
Bordeaux, Dijon, Lille, Lyon, Marseille, Nice, Paris, Saint-Herblain
2014-12-19
Active, closed
ETOP IBCSG Partners Foundation
Not applicable
518
Bordeaux, Lille, Lyon, Paris
2014-12-04
Active, closed
University Hospital, Toulouse
Observational
199
Bordeaux, Toulouse
2014-12
Recruiting
Immuno-Genetic, Inflammation, Retro-Virus, Environment
NCT02878408Bipolar Disorder, Schizophrenia
Pr. Marion Leboyer
Not applicable
1,100
Créteil, Bordeaux, Paris, Pontoise
2014-11-07
Active, closed
Eli Lilly and Company
Phase 3
493
Bordeaux, Lyon, Brest, Dijon, Saint-Brieuc, Montpellier, Saint-Herblain, Nancy
2014-11-06
Recruiting
Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients
NCT02275286Liposarcoma, Myxoid, Sarcoma, Soft Tissue, Leiomyosarcoma, Liposarcoma
Grupo Espanol de Investigacion en Sarcomas
Phase 1/2
199
Bordeaux, Lyon
2014-11
Active, closed
Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents
NCT02264678Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer
AstraZeneca
Phase 1
358
Bordeaux, Lyon, Saint-Herblain, Villejuif
2014-10-31
Recruiting
Centre Hospitalier Universitaire, Amiens
Phase 2
50
Amiens, Bordeaux, Dijon, Lille, Lyon, Marseille, Montpellier, Nancy
2014-09-12
Recruiting
UNICANCER
Observational
42,000
Angers, Bordeaux, Caen, Clermont-Ferrand, Dijon, Lille, Lyon, Marseille
2014-07
Recruiting
Imagine Institute
Observational
1,445
Bordeaux, Bron, Lille, Marseille, Paris, Rennes, Strasbourg, Toulouse
2014-06-16
Active, closed
PERIGON Pivotal Trial
NCT02088554Aortic Stenosis
Medtronic Cardiac Surgery
Not applicable
1,312
Bordeaux, Paris
2014-05-12
Active, closed
University Hospital, Toulouse
Observational
1,700
Bordeaux, Clichy, Lille, Lyon, Marseille, Montpellier, Nice, Paris
2014-05
Recruiting
Treatment of Brain AVMs (TOBAS) Study
NCT02098252Unruptured Brain Arteriovenous Malformation, Ruptured Brain Arteriovenous Malformation, Arteriovenous Malformations, AVM
Centre hospitalier de l'Université de Montréal (CHUM)
Not applicable
1,000
Brest, Besançon, Bordeaux, Caen, Clermont-Ferrand, Dijon, Le Kremlin-Bicêtre, Limoges
2014-05
Recruiting
Observational Study to Evaluate Long-Term Outcome in Hip Arthroplasty
NCT02230826Hip Replacement, Primary, Secondary or Post-traumatic Osteoarthrosis, Femur Head Necrosis, Congenital Dislocations
Corin
Observational
2,500
Bordeaux, Cannes, Dunkirk, Hénin-Beaumont, Nice, Orléans, Paris, Pessac
2014-05
Active, closed
AstraZeneca
Phase 3
1,837
Avignon, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dechy, La Roche-sur-Yon
2014-04-22
Active, closed
UNICANCER
Phase 2
1,460
Angers, Avignon, Bordeaux, Caen, Clermont-Ferrand, Dijon, La Roche-sur-Yon, Lille
2014-04-07
Recruiting
Centre Leon Berard
Phase 2
900
Bordeaux, Lyon, Marseille, Paris, Strasbourg, Toulouse
2014-03
By invitation
Juvenile Inflammatory Rheumatism (JIR) Cohorte
NCT02377245Arthritis, Juvenile Rheumatoid
Michaël Hofer
Observational
15,000
Belfort, Besançon, Bordeaux, Brest, Bron, Clermont-Ferrand, Grenoble, Le Kremlin-Bicêtre
2014-01
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,207
Angers, Besançon, Bordeaux, Caen Cédex 05, Clermont-Ferrand, Hyers, La Roche-sur-Yon, Le Mans
2013-10-14
Active, closed
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
NCT01874353Platinum Sensitive, BRCA Mutated, Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemotherapy
AstraZeneca
Phase 3
327
Bordeaux, Caen, Lyon, Nantes, Paris, Pierre-Bénite, Saint-Cloud, Toulouse
2013-09-03
Active, closed
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
NCT01844986Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV, BRCA Mutation
AstraZeneca
Phase 3
450
Bordeaux, Caen, Lyon, Nantes, Paris, Vandœuvre-lès-Nancy, Villejuif
2013-08-26
Active, closed
Novartis Pharmaceuticals
Phase 3
240
Bordeaux, Le Kremlin-Bicêtre, Marseille, Montpellier, Toulouse
2013-07-26
Recruiting
Pitié-Salpêtrière Hospital
Observational
800
Angers, Strasbourg, Marseille, Caen, Brest, Nîmes, Bordeaux, Toulouse
2013-07-11
Recruiting
Javier P. Gisbert
Observational
10,000
Bordeaux
2013-06
Recruiting
St. Anna Kinderkrebsforschung
Phase 2/3
1,800
Bordeaux, Clermont-Ferrand, Grenoble, Lille, Lyon, Marseille, Montpellier, Nancy
2013-04
Recruiting
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
NCT01522183Atypical Hemolytic-Uremic Syndrome
Alexion Pharmaceuticals, Inc.
Observational
3,000
Amiens, Angers, Bayonne, Bordeaux, Brest, Bron, Caen, Chambéry
2013-03-18
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
6,000
Amiens, Annecy, Besançon, Bobigny, Bordeaux, Boulogne-Billancourt, Brest, Caen
2013-02
Active, closed
UNICANCER
Phase 2
120
Angers, Avignon, Besançon, Bordeaux, Brest, Caen, Chambéry, Créteil
2012-12
Recruiting
COsegregation of VARiants in Panel of Genes
NCT01689584Gene Mutation-Related Cancer, Genetic Predisposition
Institut Curie
Not applicable
11,000
Bastia, Saint-Cloud, Amiens, Angers, Angoulême, Avignon, Besançon, Bordeaux
2012-07-02
Recruiting
CHDI Foundation, Inc.
Observational
35,000
Strasbourg, Amiens, Angers, Bordeaux, Clermont-Ferrand, Créteil, Lille, Marseille
2012-07
Active, closed
Radical Fimbriectomy for Young BRCA Mutation Carriers
NCT01608074BRCA1 Mutation, BRCA2 Mutation, Hereditary Breast and Ovarian Cancer
Centre Oscar Lambret
Not applicable
123
Aix-en-Provence, Bordeaux, Clermont-Ferrand, Lille, Lyon, Marseille, Nice, Paris
2012-01-09
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Avignon, Bordeaux, Boulogne-Billancourt, Brest, Caen, Chambray, Clermont-Ferrand, Créteil
2012-01
Recruiting
University Hospital, Bordeaux
Observational
30,000
Angers, Bordeaux, Cabestany, Caen, Chalon-sur-Saône, Clermont-Ferrand, Colmar, Corbeil-Essonnes
2011-12
Recruiting
French Childhood Cancer Survivor Study
NCT01620372Childhood Solid Tumor
Institut National de la Santé Et de la Recherche Médicale, France
Observational
18,000
Amiens, Angers, Besançon, Bordeaux, Caen, Clermont-Ferrand, Dijon, Grenoble
2011-11-15
Active, closed
UNICANCER
Phase 3
700
Amiens, Besançon, Bordeaux, Brest, Créteil, Dijon, La Roche-sur-Yon, Lille
2011-07
Active, closed
Associazione Qol-one
Phase 2
174
Amiens, Avignon, Bayonne, Bobigny, Bordeaux, Boulogne-sur-Mer, Caen, Créteil
2011-06-11
Active, closed
UNICANCER
Phase 3
415
Amiens, Angers, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble
2011-04-26
Active, closed
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
NCT01272037Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma
National Cancer Institute (NCI)
Phase 3
5,018
Angers, Auch, Avignon, Bayonne, Beauvais, Blois, Bordeaux, Brest
2011-02-28
Active, closed
UNICANCER
Not applicable
1,006
Amiens, Bordeaux, Brivé, Caen, Chambéry, Créteil, Dechy, Grenoble
2010-12-27
Active, closed
Vismodegib in Treating Patients With Advanced Chondrosarcomas
NCT01267955Clear Cell Chondrosarcoma, Dedifferentiated Chondrosarcoma, Locally Advanced Chondrosarcoma, Mesenchymal Chondrosarcoma
National Cancer Institute (NCI)
Phase 2
45
Bordeaux, Lille, Lyon, Marseille, Paris, Villejuif
2010-12-21
Recruiting
OBS'CEREVANCE: French Cohort of Pediatric Autoimmune Cytopenia
NCT05937828Immune Thrombocytopenia, Autoimmune Hemolytic Anemia, Evans Syndrome
University Hospital, Bordeaux
Observational
3,500
Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Paris
2010-09-01
Active, closed
Institut Curie
Phase 2
195
Saint-Denis, Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand
2010-03-18
Recruiting
Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIAL-MR)
NCT06911099Atrial Functional Mitral Regurgitation, Mitral Insufficiency
University Hospital of Cologne
Observational
1,000
Bordeaux, Nantes
2010-01-01
Recruiting
Institut Bergonié
Observational
150,000
Bordeaux, Lyon, Villejuif
2010-01-01
Recruiting
Saint-Louis Hospital, Paris, France
Not applicable
575
Amiens, Bordeaux, Clermont-Ferrand, Clichy, Créteil, Le Kremlin-Bicêtre, Lille, Marseille
2009-12-10
Active, closed
Institut Bergonié
Observational
265
Bordeaux, Dijon, Montpellier
2009-09
Active, closed
UNICANCER
Not applicable
500
Angers, Bordeaux, Caen, Chambéry, Chambray-lès-Tours, Créteil, Lyon, Marseille
2008-10
Active, closed
UNICANCER
Phase 3
318
Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble
2007-03
Recruiting
Pompe Disease Registry Protocol
NCT00231400Glycogen Storage Disease Type II, Pompe Disease
Genzyme, a Sanofi Company
Observational
2,000
Bordeaux, Brest, Bron, Caen, La Tronche, Lille, Marseille, Nancy
2004-09-15
Recruiting
Understanding the Long-term Paths of People With Addictions
NCT07249970Addiction Disorders, Addictive Behaviors, Addiction
Centre Hospitalier Charles Perrens, Bordeaux
Observational
10,000
Bordeaux
2002-03-12
Recruiting
Genzyme, a Sanofi Company
Observational
9,000
Bordeaux, Bron, Garches, Lille, Saint-Priest-en-Jarez, Strasbourg
2001-07-31
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
1,649
Ambilly, Annecy, Aulnay-sous-Bois, Avignon, Bayonne, Besançon, Béziers, Bordeaux
1998-10
By invitation
Copenhagen University Hospital, Rigshospitalet
Observational
23,000
Bordeaux, Lyon, Nice, Paris
1994-01
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease
Genzyme, a Sanofi Company
Observational
12,000
Besançon, Bordeaux, Brest, Bron, Caen, Clichy, Garches, Lyon
1991-04-01
Recruiting
Institut Bergonié
Observational
30,000
Bordeaux
1990-01
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
615
Bordeaux, Caen, Compiègne, Dijon, Lyon, Nice, Paris, Pierre-Bénite
1989-09
Rows per page Showing 1001–1389 of 1389
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 October 2026. https://priyalifescience.com/clinical-trials-france/city/bordeaux?page=3

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,697 studies in total at the last sync on 26 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,389 of those studies with a site in Bordeaux.

How many clinical trials are recruiting in Bordeaux?

755 of the 1,389 studies on this page are recruiting new participants as of the 26 Oct 2026, 03:20 UTC sync. A further 110 have not yet opened recruitment, 515 are active but closed to new participants, and 9 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.